Data lead to answers.
Fundamental to public health research and policy, biostatistics is also one of the most interdisciplinary departments at Boston University School of Public Health. By designing studies, developing new methodologies, and extracting and analyzing information from data, we help inform decisions to promote better health.
Biostatistics faculty members are internationally recognized for methodological innovations in clinical trials and observational studies, statistical genetics analysis, and Bayesian methods. They have a long history of collaborating to address some of the world’s most pressing public health concerns, as well as training the next generation of students to tackle emerging public health and medical issues with cutting-edge methods and technological skills.
Areas in which we are active include genetic studies of risk factors for breast cancer; safety and efficacy assessments of a new Alzheimer’s disease drug; comparisons of patient outcomes with different behavioral interventions; and studies to identify genetic and non-genetic factors of healthy aging and extreme human longevity.
Affiliated Academic Programs:
Recent Department News
Latest Publications
- Published On 11/18/2024Association of cognitive and structural correlates of brain aging and incident epilepsy. The Framingham Heart Study.Epilepsiaread at PubMed
- Published On 11/16/2024Enteral and Parenteral Nutrition Timing in eICU Collaborative Research Database by Race: A Retrospective Observational Study.The Journal of surgical researchread at PubMed
- Published On 11/16/2024Polygenic Risk Scores for Coronary Heart Disease: An Unfulfilled Promise of Precision Medicine.JAMAread at PubMed
- Published On 11/15/2024Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and Risks.Clinical infectious diseases : an official publication of the Infectious Diseases Society of Americaread at PubMed
- Published On 11/14/2024Sex-Specific Vulnerabilities to Subclinical Vascular Brain Injury in Early Late-Life: The Framingham Heart Study.Annals of neurologyread at PubMed